DEFERASIROX | A206585 | PHARMOBEDIENT CONSULTING LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc. 2 patentsANDA 206585deferasirox | D. Del. | 2014-06-25 | Terminated 2015-10-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.